Answer
Biktarvy is not recommended for patients with severe hepatic impairment (Child-Pugh Class C) because it has not been studied in this population.
Sources for this answer
- Biktarvy 50 mg/200 mg/25 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.2 Posology and method of administration · Version 21Document updated
Sources checked